Hearing Loss Trial, Recruiting (NCT07505667)

Hearing Loss Trial, Recruiting NCT07505667 Sponsor: Guangdong Provincial People's Hospital Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT07505667 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have had a sudden drop in hearing in one ear only, where the hearing loss started within the last 72 hours and affected at least two connected sound frequencies by 20 decibels or more.
People who are able to be enrolled in the trial within 14 days of when the hearing loss began.
People aged 18 to 60 years old, of any gender.
People who are able to understand the study procedures and attend follow-up appointments as required.

Who may not be able to join:

People who are currently pregnant or breastfeeding.
People with a history of long-term ear disease, previous ear surgery, an immune system-related hearing condition, or a confirmed diagnosis of Meniere's disease.
People who have received steroid (corticosteroid) medication for any reason in the 30 days before joining the trial.
People who have an autoimmune condition or a long-term inflammatory disease.
People with serious liver or kidney problems.
People who have any other health condition that the trial doctor considers would make participation unsuitable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18737552662

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07505667

Sponsor: Guangdong Provincial People's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: +86 18737552662

More information: https://clinicaltrials.gov/study/NCT07505667

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have had a sudden drop in hearing in one ear only, where the hearing loss started within the last 72 hours and affected at least two connected sound frequencies by 20 decibels or more.
People who are able to be enrolled in the trial within 14 days of when the hearing loss began.
People aged 18 to 60 years old, of any gender.
People who are able to understand the study procedures and attend follow-up appointments as required.

Who may not be able to join:

People who are currently pregnant or breastfeeding.
People with a history of long-term ear disease, previous ear surgery, an immune system-related hearing condition, or a confirmed diagnosis of Meniere's disease.
People who have received steroid (corticosteroid) medication for any reason in the 30 days before joining the trial.
People who have an autoimmune condition or a long-term inflammatory disease.
People with serious liver or kidney problems.
People who have any other health condition that the trial doctor considers would make participation unsuitable (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Guangdong Provincial People's Hospital

Registry

ClinicalTrials.gov

Start date

15 November 2025

Est. completion

15 November 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Pure-Tone Audiometry Hearing Threshold (dB HL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov